Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, and Cancer Immunotherapy and Biomarkers.
Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial
Electro-acupuncture for quality of life during adjuvant chemotherapy in gastric cancer: a randomized trial
Huang-qin decoction increases the sensitivity of EGFR-TKIs to NSCLC cells by regulating stat3/GPX4 to induce redox ratio and ROS to inhibit CSCs
Exploring the mechanisms of Hu-gu-xiao-ji formula and its components for treatment on non-small cell lung cancer using UPLC-QTOF-MS/MS, network pharmacology, and experiments
Xie-Bai-San increases NSCLC cells sensitivity to gefitinib by inhibiting Beclin-1 mediated autophagosome formation
BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells
Electro-acupuncture for health-related quality of life and symptoms in patients with gastric cancer undergoing adjuvant chemotherapy (EAGER): a protocol for a multicenter randomized controlled trial
Prognostic and metabolic characteristics of a novel cuproptosis-related signature in patients with hepatocellular carcinoma
PD-1 Combined with VEGF/VEGFR2 Inhibitors for the Re-Treatment of Metastatic Nasopharyngeal Carcinoma
Prognostic and Metabolic Characteristics of a Novel Cuproptosis Related Signature in Hepatocellular Carcinoma Patients
Bone metastasis attenuates efficacy of immune checkpoint inhibitors and displays “cold” immune characteristics in Non-small cell lung cancer
Lung cancer organoids, a promising model still with long way to go
The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
Dissecting the ferroptosis-related prognostic biomarker and immune microenvironment of driver gene-negative lung cancer
Erratum to “Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models”
Retracted: Effect of Sham Acupuncture on Chronic Pain: A Bayesian Network Meta-Analysis
Authors’ Response to Dr. Zhang on the Methodological and Sham Acupuncture Issues
Acupuncture for Quality of Life in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy
Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with ALK-rearranged: a meta-analysis of clinical trials
Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models
A Clinical Nomogram for Predicting Cancer-Specific Survival in Pulmonary Large-Cell Neuroendocrine Carcinoma Patients: A Population-Based Study
A phaseⅠ/Ⅱa clinical study of cetuximab combined with fruquintinib in the third-line treatment of RAS/BRAF wild-type colorectal cancer.
Specific Gene Co-variation Acts Better Than Number of Concomitant Altered Genes in Predicting EGFR-TKI Efficacy in Non–small-cell Lung Cancer
Combination with cooling-heat Chinese medicine Qing-kai-ling, not warming-yang Shen-fu, enhances the antitumor effect of gefitinib in resistant non-small cell lung cancer models in vitro and in vivo
Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients
Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC
Estimation of cell-free circulating <i>EGFR</i> mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs
Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer